S&P 500 Index

SPX
2,541.47
-88.60 (-3.37%)
StockTwits Share  Twitter Share  Facebook Share

China Coronavirus Outbreak Hits New Low in Mortality Rate and Reported Death Increase Rate





Date Published:
Author: CMLviz News

 

Highlights

More than 99% of reported cases worldwide are in China. While headlines point to cases in other regions, the perspective seems to be missing.

* To date, only one death has been reported outside of China  (and this data does not rely on trusting the Chinese government's numbers).
 
* Daily mortality rates hit a new low on February 1, 2020.
 
* Day over day death per cent increases hit a new low on February 1, 2020.
 
* While calmer heads should always prevail, there is reason to question the accuracy of the data.

* This virus is spreading rapidly and is deadly. 

 

Lede

Based on daily data pulled from the Yuan Talks surrounding China's coronavirus outbreak, the daily mortality rate (2.11%) and the daily rate of increase in reported deaths (17.4%) has hit a new low. Additionally, the daily rate of increase in number of reported cases notched its second lowest reading, with only the day prior showing a smaller increase in reported cases.

 

Further, while there are reports of the virus spreading well outside of China, as of today, the World Health Organization reports that over 99% of cases are in China (14,248 cases out of 14,380).  That is not to minimize the risk of contagion, it is simply a matter of reported fact.

 

Caution in Using Available Data

There are reasons to be cautious with the numbers reported out of China surrounding the coronavirus. On January 30th, 2020 STAT wrote "Limited data may be skewing assumptions about severity of coronavirus outbreak, experts say."

 

Here is a crucial snippet from the article:

 

The approach, the experts told STAT, is likely resulting in both an underestimate in the total number of cases and flawed assumptions about fatality rates calculated by those who ignore the repeated caution that it’s too soon to do that math.

The experts were quick to note that the Chinese are not willfully underreporting cases. Rather, the approach is a testament to how challenging data collection can be during the early days of an epidemic. When thousands of sick people show up at hospitals looking for care, there is no time to go searching for people who have mild symptoms and who have stayed home.

 

Data

With a the caveat that the data may not be fully accurate, we can still examine the rates of change, which even if the data is wrong, could give us a clue as to the direction of the virus' proliferation.

In the table below we share the daily number of reported confirmed cases, the per cent increase, the daily number of reported deaths, the per cent increase, and finally the daily mortality rate, respectively.

 

As the lede indicates, the daily mortality rate (2.11%) and the daily rate of increase in reported deaths (17.4%) has hit a new day over day low. Additionally, the daily rate of increases in the number of reported cases notched its second lowest reading, with only the day prior showing a smaller increase.

Further, the data also avails itself to a reported mortality rate trend -- it has stabilized.

The data has another conclusion which is undisputed, this virus appears to be spreading rapidly and is deadly. 

We conclude with a message from the World Health Organization, made on February 1, 2020:

Asymptomatic infection may be rare, and transmission from an asymptomatic person is very rare with other coronaviruses, as we have seen with Middle East Respiratory Syndrome coronavirus. Thus, transmission from asymptomatic cases is likely not a major driver of transmission. 

 

Finally, we note that to date, only one death has been reported outside of China (and this data does not rely on trusting the Chinese government's numbers).

 

Legal
The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. Capital Market Laboratories (“The Company”) does not engage in rendering any legal or professional services by placing these general informational materials on this website.

The Company specifically disclaims any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if we have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.

The Company make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that The Company endorses, sponsors, promotes or is affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.